FIELD: chemistry.
SUBSTANCE: present invention relates to the field of medical chemistry and in particular relates to 4-(substituted five-membered heterocyclic pyrimidine/pyridine) amino-1H-3-pyrazolecarboxamide derivatives of formula (I), in which the radicals and symbols are defined in the claims. Compounds of formula (I) are protein kinase inhibitors. (I).
EFFECT: invention also relates to a pharmaceutical composition comprising said compounds, and to their use in medicine as an antitumor agent.
12 cl, 1 dwg, 7 tbl, 58 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND METHODS FOR USE THEREOF | 2007 |
|
RU2468027C2 |
PHARMACEUTICAL COMPOUNDS | 2005 |
|
RU2422449C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | 2014 |
|
RU2677653C2 |
DIAMINOTRIAZOLES, SUITABLE AS INHIBITORS OF PROTEIN KINASES | 2003 |
|
RU2350606C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
METHOD FOR OBTAINING AROMATIC HETEROCYCLIC COMPOUND USED AS SELECTIVE INHIBITOR OF KINASE JAK1 AND APPLICATION THEREOF | 2015 |
|
RU2671195C2 |
HETEROARYL COMPOUNDS AS IRAK TYPE II INHIBITORS AND THEIR USE | 2019 |
|
RU2810338C2 |
THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
Authors
Dates
2018-05-30—Published
2014-01-07—Filed